BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 735882)

  • 1. Interaction by cholestyramine on the uptake of hydrocortisone in the gastrointestinal tract.
    Johansson C; Adamsson U; Stierner U; Lindsten T
    Acta Med Scand; 1978; 204(6):509-12. PubMed ID: 735882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of sodium taurocholate, cholestyramine, and mylanta on the intestinal absorption of glucocorticoids in the rat.
    Ware AJ; Combes B
    Gastroenterology; 1973 Jun; 64(6):1150-5. PubMed ID: 4706135
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitory effect of cholestyramine on the absorption of flufenamie and mefenamic acids in rats.
    Rosenberg HA; Bates TR
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):93-8. PubMed ID: 4812876
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-cholestyramine interactions. II. Influence of cholestyramine on GI absorption of sodium fusidate.
    Johns WH; Bates TR
    J Pharm Sci; 1972 May; 61(5):735-9. PubMed ID: 5035781
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cholestyramine on digoxin absorption and excretion in man.
    Hall WH; Shappell SD; Doherty JE
    Am J Cardiol; 1977 Feb; 39(2):213-6. PubMed ID: 835478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of pancreatic growth and gallbladder contractility by bile salts.
    Gomez G; Townsend CM; Maani R; Singh P; Greeley GG; Thompson JC
    Am J Surg; 1989 Jan; 157(1):20-6. PubMed ID: 2910123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment by cholestyramine of dicumarol and tromexan absorption in rats: a potential drug interaction.
    Tembo AV; Bates TR
    J Pharmacol Exp Ther; 1974 Oct; 191(1):53-9. PubMed ID: 4138553
    [No Abstract]   [Full Text] [Related]  

  • 8. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.
    Caldwell JH; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2626-37. PubMed ID: 5129314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of methotrexate metabolism in rats by administration of an elemental liquid diet. II. Reduced toxicity and improved survival using cholestyramine.
    McAnena OJ; Ridge JA; Daly JM
    Cancer; 1987 Mar; 59(6):1091-7. PubMed ID: 3815282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rHDL administration increases reverse cholesterol transport in mice, but is not additive on top of ezetimibe or cholestyramine treatment.
    Maugeais C; Annema W; Blum D; Mary JL; Tietge UJ
    Atherosclerosis; 2013 Jul; 229(1):94-101. PubMed ID: 23725986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cholestyramine and colestipol on the absorption of hydrochlorothiazide.
    Hunninghake DB; King S; LaCroix K
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):151-4. PubMed ID: 7076343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholestyramine influences meal-stimulated pancreaticobiliary function and plasma cholecystokinin independent of gastric emptying and food digestion.
    Thimister PW; Hopman WP; Loualidi A; Rosenbusch G; Willems HL; Trijbels FJ; Jansen JB
    Scand J Gastroenterol; 1997 Aug; 32(8):778-84. PubMed ID: 9282969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cholestyramine and colestipol on the absorption of phenytoin.
    Callaghan JT; Tsuru M; Holtzman JL; Hunninghake DB
    Eur J Clin Pharmacol; 1983; 24(5):675-8. PubMed ID: 6873150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of bile reflux-induced acute gastric ulceration in the rat by cholestyramine.
    Mersereau WA; Hinchey EJ
    Ann Surg; 1974 Jun; 179(6):883-8. PubMed ID: 4835507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psyllium augments the cholesterol-lowering action of cholestyramine in hamsters by enhancing sterol loss from the liver.
    Turley SD; Daggy BP; Dietschy JM
    Gastroenterology; 1994 Aug; 107(2):444-52. PubMed ID: 8039621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of cholesterol absorption inhibitors devoid of secondary intestinal effects.
    Marquet F; Abou el Fadil F; Boubia B; Guffroy C; Pansu D; Descroix-Vagne M
    Reprod Nutr Dev; 1997; 37(6):691-707. PubMed ID: 9477437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cholestyramine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Frey R; Wetzelsberger N; Lücker PW; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):250-4. PubMed ID: 9208341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levothyroxine-cholestyramine interaction reemphasized.
    Harmon SM; Seifert CF
    Ann Intern Med; 1991 Oct; 115(8):658-9. PubMed ID: 1892339
    [No Abstract]   [Full Text] [Related]  

  • 19. Bile salt and non-bile salt components in bile affecting micellar cholesterol uptake by rat intestine in vitro.
    Rampone AJ
    J Physiol; 1972 Dec; 227(3):889-98. PubMed ID: 4650941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant administration of cholestyramine influences the absorption of troglitazone.
    Young MA; Lettis S; Eastmond R
    Br J Clin Pharmacol; 1998 Jan; 45(1):37-40. PubMed ID: 9489592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.